Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT) Olga Sánchez-SoliñoRyan D. KilpatrickGregory C. Gray Brief Report Open access 10 March 2024 Pages: 633 - 645
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations Alexy InciarteLorena de la MoraJosep Mallolas Case Report Open access 03 April 2024 Pages: 647 - 658
Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines Ann R. FalseyStefania MaggiTor Biering-Sørensen Commentary Open access 14 March 2024 Pages: 659 - 666
Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia Nada K. AlhumaidAreej M. AlajmiEssam A. Tawfik Original Research Open access 10 March 2024 Pages: 667 - 684
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey Jennie H. BestMitra SadeghiMarcus J. Zervos Original Research Open access 14 March 2024 Pages: 685 - 697
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination Timothy E. AlbertsonCaitlin Hansenthe C4591031, C4591007 Clinical Trial Groups Original Research Open access 15 March 2024 Pages: 699 - 714
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact Carolina Garcia-VidalChristian Teijón-LumbrerasAlex Soriano Original Research Open access 15 March 2024 Pages: 715 - 726
Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study Zhikai WanJunwei SuBiao Zhu Original Research Open access 15 March 2024 Pages: 727 - 744
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions Mark H. RozenbaumErica ChilsonMark Atwood Original Research Open access 16 March 2024 Pages: 745 - 760
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia Ru HanPeter San MartinDésirée A. M. van Oorschot Original Research Open access 17 March 2024 Pages: 761 - 778
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework Sushma KavikondalaKatrin HaeusslerEkkehard Beck Original Research Open access 18 March 2024 Pages: 779 - 811
Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study Yu-Yuan WangWei-Wen ZhangMing-xia Jing Original Research Open access 18 March 2024 Pages: 813 - 826
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States Daniel MolnarElizabeth M. LaDesmond Curran Original Research Open access 20 March 2024 Pages: 827 - 844
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019 Aleksandra Polkowska-KramekElizabeth BegierGernot Rohde Original Research Open access 23 March 2024 Pages: 845 - 860
Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections Yuan-Yuan LiYan ChenBin Du Original Research Open access 27 March 2024 Pages: 861 - 874
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses Paul BensonJennifer KuretskiAlan Oglesby Original Research Open access 03 April 2024 Pages: 875 - 889
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study Stefan SchneiderGary BlickAlan Oglesby Original Research Open access 03 April 2024 Pages: 891 - 906
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany Sebastian GruhnManuel BatramOliver Damm Original Research Open access 04 April 2024 Pages: 907 - 920
Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies Germaine HanquetChristian TheilackerElizabeth Begier Review Open access 18 March 2024 Pages: 921 - 940
Effect of Infusion Set Replacement Intervals on Central Line-Associated Bloodstream Infection in the Intensive Care Unit: Study Protocol of the INSPIRATION Study Dandan XuChang HuOn behalf of the INSPIRATION Study group Study Protocol Open access 14 March 2024 Pages: 941 - 951
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol Robin BruyndonckxAleksandra Polkowska-KramekElizabeth Begier Study Protocol Open access 18 March 2024 Pages: 953 - 963
